Celldex Therapeutics reported $46.46M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Celldex Therapeutics USD 46.46M 13.5M Sep/2025
Glaxosmithkline GBP 28.68B 8.3B Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025